Sequence Similarity Clusters for the Entities in PDB 3TCL

Entity #1 | Chains: A,H
CH04 Heavy Chain Fab protein, length: 237 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 1 4 11371
95 % 1 4 10972 Flexibility: Low
Max RMSD: 3.0, Avg RMSD: 1.5
PDBFlex
90 % 1 4 10898
70 % 454 2532 2
50 % 931 5226 1
40 % 1129 5890 1
30 % 1374 7330 1
Entity #2 | Chains: B,L
CH04 Light Chain Fab protein, length: 215 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 1 2 22666
95 % 1 2 20278 Flexibility: Low
Max RMSD: 2.3, Avg RMSD: 1.5
PDBFlex
90 % 151 783 1
70 % 453 2576 1
50 % 932 5226 1
40 % 1130 5890 1
30 % 1375 7330 1

Instructions

In the table for each entity, view a list of similar sequences by selecting the link associated with the percentage cutoff.



View more detailed documentation on the redundancy reduction and sequence clustering procedure used by RCSB PDB.

You can also use the structure comparison tool to compare any 2 given structures


ACTION - (A) Select for download / view details OR (B) Select two chains for comparison
Rank PDB ID Entity ID Chains Description Details Taxonomy EC Number
1 4NZU 1 L 13PL heavy chain Fab 9606
2 4NZU 2 H 13PL light chain Fab 9606
3 1MJU 1 L IMMUNOGLOBULIN MS6-12 Fab fragment, LIGHT CHAIN 10090
4 1MJU 2 H IMMUNOGLOBULIN MS6-12 Fab fragment, HEAVY CHAIN 10090
5 4TRP 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
6 4TRP 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
7 1MEX 1 L Fab 29G12 light chain 10090
8 1MEX 2 H Fab 29G12 heavy chain 10090
9 3D9A 2 L Light Chain of HyHel10 Antibody Fragment (Fab) 10090
10 3D9A 3 H Heavy Chain of HyHel10 Antibody Fragment (Fab) 10090
11 4BUH 1 A, B CLONE M0418 SCFV 9606
12 3TV3 1 L PGT128 light chain, Ig lambda-2 chain C regions PGT128 light chain 9606
13 3TV3 2 H PGT128 heavy chain, Ig gamma-1 chain C region PGT128 heavy chain 9606
14 1NCW 1 L IMMUNOGLOBULIN IGG2A Antibody FAB fragment 4C6, light chain 10090
15 1NCW 2 H IMMUNOGLOBULIN IGG2A Antibody FAB fragment 4C6, heavy chain 10090
16 5YD4 1 A, C, E, G scFv 4B08 10090
17 5YD3 1 A, C, E, G scFv 4B08 10090
18 5UD9 1 H Fab heavy chain 9606
19 5UD9 2 L Light chain 9606
20 5TY6 1 H VRC 315 13-1b02 Fab Heavy chain 9606
21 5TY6 2 L VRC 315 13-1b02 Fab Light chain 9606
22 2XZC 1 H FAB A.17 HEAVY CHAIN 9606
23 2XZC 2 L FAB A.17 LIGHT CHAIN 9606
24 2XKN 1 A, C ANTI-EGFR ANTIBODY 7A7 FAB FRAGMENT LIGHT CHAIN (IGG1), RESIDUES 1-223 10090
25 2XKN 2 B, D ANTI-EGFR ANTIBODY 7A7 FAB FRAGMENT HEAVY CHAIN (IGG1), RESIDUES 1-216 10090
26 5KVG 2 L ZV-67 Antibody Fab Light Chain 10090
27 5KVG 3 H ZV-67 Antibody Fab Heavy Chain 10090
28 5WCA 1 H VRC315 27-1C08 Fab Heavy chain 9606
29 5WCA 2 L VRC315 27-1C08 Fab Light chain 9606
30 4XCF 1 L 4E10 Fab light chain 9606
31 4XCF 2 H 4E10 Fab heavy chain 9606
32 5KVF 2 L ZV-64 Antibody Fab Light Chain 10090
33 5KVF 3 H ZV-64 Antibody Fab Heavy Chain 10090
34 1RUP 1 L immunoglobulin igg2a, heavy chain fab 10090
35 1RUP 2 H immunoglobulin igg2a, light chain fab 10090
36 1RUK 1 L immunoglobulin igg2a, light chain fab 10090
37 1RUK 2 H immunoglobulin igg2a, heavy chain fab 10090
38 5VXR 1 H MAb24 Variable Heavy Chain,MAb24 Variable Heavy Chain 10090
39 5VXR 2 L MAb24 Variable Light Chain,MAb24 Variable Light Chain 10090
40 5X08 1 H Fab 4E10 Heavy chain 9606
41 5X08 2 L Fab 4E10 Light chain 9606
42 4XAW 1 L 4E10 Fab light chain 9606
43 4XAW 2 H 4E10 Fab heavy chain 9606
44 3N9G 1 H Fab fragment of MAb CR4354, heavy chain 9606
45 3N9G 2 L Fab fragment of MAb CR4354, light chain 9606
46 4TUL 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
47 4TUL 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
48 5UCB 1 H Fab Heavy Chain 9606
49 5UCB 2 L Fab Light Chain 9606
50 2VXV 1 H HUMAN IGG ABT-325 9606
51 2VXV 2 L HUMAN IGG ABT-325 9606
52 4GXV 1 H, I Antibody 1F1, heavy chain 9606
53 4GXV 2 L, M Antibody 1F1, light chain 9606
54 2VXT 1 H MURINE IGG 125-2H 10090
55 2VXT 3 L MURINE IGG 125-2H 10090
56 1RUM 1 L immunoglobulin igg2a, light chain fab 10090
57 1RUM 2 H immunoglobulin igg2a, heavy chain fab 10090
58 2XZA 1 H FAB A.17 HEAVY CHAIN 9606
59 2XZA 2 L FAB A.17 LIGHT CHAIN 9606
60 2W60 1 A ANTI-CITRULLINATED COLLAGEN TYPE II FAB ACC4 10090
61 2W60 2 B ANTI-CITRULLINATED COLLAGEN TYPE II FAB ACC4 10090
62 5W24 1 L 5C4 Fab Light Chain 10090
63 5W24 2 H 5C4 Fab Heavy Chain 10090
64 4HPY 1 H CH59 Fab heavy chain 9606
65 4HPY 2 L CH59 Fab light chain 9606
66 3T65 1 B S25-2 FAB (IGG1K) heavy chain 10090
67 3T65 2 A S25-2 FAB (IGG1K) light chain 10090
68 5C6W 1 H, J Protein IGHV1-69-2,Ig lambda chain V-II region NIG-84 9606
69 4JG1 1 L Fab light chain 9606
70 4JG1 2 H Fab heavy chain 9606
71 3M8O 1 L IMMUNOGLOBULIN A1 LIGHT CHAIN Fab fragment 9606
72 3M8O 2 H IMMUNOGLOBULIN A1 HEAVY CHAIN Fab fragment 9606
73 5VF2 1 A scFv 2D10 10090
74 5I8C 1 A VRC34.01 Fab heavy chain 9606
75 5I8C 2 B VRC34.01 Fab light chain 9606
76 4O5L 1 L Fab F045-092 light chain 9606
77 4O5L 2 H Fab F045-092 heavy chain 9606
78 5MYX 1 A, C Fab c#24 light chain 10090
79 5MYX 2 B, D Fab c#24 heavy chain Pyroglutamate residue 1 (PCA) results from post-translational modification of original residue glutamine 1. 10090
80 3IFL 1 L 12A11 FAB antibody light chain 10090
81 3IFL 2 H 12A11 FAB antibody heavy chain 10090
82 5WK2 1 L M116 LIGHT CHAIN 9606
83 5WK2 2 H M116 HEAVY CHAIN FD 9606
84 3PP4 1 H GA101 Fab heavy chain 10090
85 3PP4 2 L GA101 Fab light chain 10090
86 3KDM 1 A, L Immunoglobulin light chain 9606
87 3KDM 2 B, H Immunoglobulin heavy chain 9606
88 5NIV 1 A Light chain of 5D3 Fab 10090
89 5NIV 2 B Heavy chain of 5D3 Fab 10090
90 5N4J 1 L LIGHT CHAIN 9606
91 5N4J 2 H HEAVY CHAIN the sequence provided include the cleavable tag 9606
92 2AJU 1 L ANTIBODY 7A1 FAB' IMMUNOGLOBULIN IGG1 KAPPA LIGHT CHAIN 10090
93 2AJU 2 H ANTIBODY 7A1 FAB' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
94 2AJV 1 L Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 KAPPA LIGHT CHAIN 10090
95 2AJV 2 H Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
96 5X4G 1 A 6H8 Fab heavy chain 10090
97 5X4G 2 B 6H8 Fab light chain 10090
98 3SY0 1 A S25-2 FAB (IGG1K) light chain 10090
99 3SY0 2 B S25-2 FAB (IGG1K) heavy chain 10090
100 4PTU 1 A Antibody pn132p2C05, light chain 9606
101 4PTU 2 B Antibody pn132p2C05, heavy chain 9606
102 4TPR 1 L If kappa light chain 10090
103 4TPR 2 H Fab heavy chain 10090
104 4HS6 2 A, L MRCT10.v362 Fab light chain 9606
105 4HS6 3 B, H MRCT10.v362 Fab heavy chain 9606
106 3IFN 1 H 12A11 FAB antibody heavy chain 10090
107 3IFN 2 L 12A11 FAB antibody light chain 10090
108 5U3P 1 H DH511.4 Fab Heavy Chain 9606
109 5U3P 2 L DH511.4 Fab Light Chain 9606
110 6BLA 1 H AMM01 Fab Heavy chain 9606
111 6BLA 2 L AMM01 Fab Light chain 9606
112 4TOY 1 H 35O22 Fab Heavy chain 9606
113 4TOY 2 L 35O22 Fab Light chain 9606
114 4TUO 1 A, C Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
115 4TUO 2 B, D Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
116 3NPS 2 B S4 FAB HEAVY CHAIN 9606
117 3NPS 3 C S4 FAB LIGHT CHAIN 9606
118 5I4F 1 A scFv 2D10 10090
119 1RUR 1 L immunoglobulin 13G5, light chain fab 10090
120 1RUR 2 H immunoglobulin 13G5, heavy chain fab 10090
121 5ADO 1 H FAB A.17 HEAVY CHAIN 9606
122 5ADO 2 L FAB A.17 LIGHT CHAIN 9606
123 5WN9 1 H scFv 2D10 9606
124 4XC3 1 L 4E10 Fab light chain 9606
125 4XC3 2 H 4E10 Fab heavy chain 9606
126 4M5Y 1 H, I Fab 5J8 heavy chain 9606
127 4M5Y 2 L, M Fab 5J8 light chain 9606
128 4TQE 1 L If kappa light chain 10090
129 4TQE 2 H Fab heavy chain 10090
130 5YY4 1 A scFv 4B08 10090
131 4ISV 1 A 1C2 FAB LIGHT CHAIN 10090
132 4ISV 2 B 1C2 FAB HEAVY CHAIN 10090
133 4XC1 1 L 4E10 FAB LIGHT CHAIN 9606
134 4XC1 2 H 4E10 FAB HEAVY CHAIN 9606
135 5VSI 1 H CH1/Ckappa Fab heavy chain 9606
136 5VSI 2 L CH1/Ckappa Fab light chain 9606
137 5ODB 1 A D10 Fab fragment - heavy chain not modeled residues are not visible in the electron density map the Fab fragment was prepared from a antibody chimera containing the variable domains of the human D10 mAb and the constant domains of mouse IgG2a heavy chain and Ig-lambda light chain 9606
138 5ODB 2 B D10 Fab fragment - light chain not modeled residues are not visible in the electron density map the Fab fragment was prepared from a antibody chimera containing the variable domains of the human D10 mAb and the constant domains of mouse IgG2a heavy chain and Ig-lambda light chain 9606
139 4CMH 2 B HEAVY CHAIN OF SAR650984-FAB FRAGMENT 10090
140 4CMH 3 C LIGHT CHAIN OF SAR650984-FAB FRAGMENT 10090
141 5JXA 1 H VRC03 Heavy chain 9606
142 5JXA 2 L VRC03 Light chain 9606
143 3QHZ 1 H, I Human monoclonal antibody del2D1, Fab Heavy Chain Fab Heavy Chain 9606
144 3QHZ 2 L, M Human monoclonal antibody del2D1, Fab Light Chain Fab Light Chain 9606
145 3UJI 1 L Light chain of anti-HIV-1 V3 monoclonal antibody 2558 9606
146 3UJI 2 H Fab region of the heavy chain of anti-HIV-1 V3 monoclonal antibody 2558 9606
147 3NTC 1 L Fab light chain 10090
148 3NTC 2 H Fab heavy chain 10090
149 4YNY 1 A, C Heavy chain of antigen binding fragment, Fab 10116
150 4YNY 2 B, D Light chain of antigen binding fragment, Fab 10116
151 4TUK 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
152 4TUK 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
153 4YO0 1 A, C Heavy chain of antigen binding fragment, Fab 10116
154 4YO0 2 B, D Light chain of antigen binding fragment, Fab 10116
155 6AZM 1 A, C 580 germline antibody, light chain Fragment: Fab 9606
156 6AZM 2 B, D 580 germline antibody, heavy chain Fragment: Fab 9606
157 6BE3 1 H Fab (F598) Heavy Chain 9606
158 6BE3 2 L Fab (F598) Light Chain 9606
159 4NWU 1 H APE1551 Ab Fab heavy chain 9606
160 4NWU 2 L APE1551 Ab Fab light chain 9606
161 3HC4 1 H IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
162 3HC4 2 L IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
163 5VZR 1 A, H G4 antibody heavy chain Fab fragment 10090
164 5VZR 2 B, L G4 antibody light chain Fab fragment 10090
165 2W9D 1 H ICSM 18-ANTI-PRP THERAPEUTIC FAB HEAVY CHAIN 10090
166 2W9D 2 L ICSM 18-ANTI-PRP THERAPEUTIC FAB LIGHT CHAIN 10090
167 5EWI 1 H VRC38.01 Heavy Chain 9606
168 5EWI 2 L VRC38.01 Light Chain 9606
169 5E2W 1 L AT8 LIGHT CHAIN 10090
170 5E2W 2 H AT8 HEAVY CHAIN 10090
171 5MYK 1 A Fab c#17 light chain 10090
172 5MYK 2 B Fab c#17 heavy chain 10090
173 4NZR 1 H PGT135 heavy chain Fab 9606
174 4NZR 2 L PGT135 light chain Fab 9606
175 5MYO 1 A, C Fab c#6 light chain 10090
176 5MYO 2 B, D Fab c#6 heavy chain 10090
177 4HBC 1 H Antigen Binding Fragment, Immunoglobulin IgG - Heavy Chain 9986
178 4HBC 2 L Antigen Binding Fragment, Immunoglobulin IgG - Light Chain 9986
179 4AEH 1 H FAB ANTIBODY, HEAVY CHAIN VARIABLE DOMAIN, RESIDUES 1-231 10090
180 4AEH 2 L FAB ANTIBODY, LIGHT CHAIN VARIABLE DOMAIN, RESIDUES 1-214 10090
181 5UEL 1 H 354NC102 Fab Heavy Chain 9606
182 5UEL 2 L 354NC102 Fab Light Chain 9606
183 3UZQ 1 A anti-dengue Mab 4E11 Single chain variable fragment 10090
184 2V17 2 H MONOCLONAL ANTIBODY FAB FRAGMENT MN423 DISULPHIDE BRIDGE BETWEEN L214 AND H137 IS REDUCED 10090
185 2V17 3 L MONOCLONAL ANTIBODY FAB FRAGMENT MN423 DISULPHIDE BRIDGE BETWEEN L214 AND H137 IS REDUCED 10090
186 4J6R 2 H HEAVY CHAIN OF ANTIBODY VRC23 9606
187 4J6R 3 L LIGHT CHAIN OF ANTIBODY VRC23 9606
188 5E2V 1 L AT8 LIGHT CHAIN 10090
189 5E2V 2 H AT8 HEAVY CHAIN 10090
190 5SY8 1 H 10E8 FAB HEAVY CHAIN 9606
191 5SY8 2 L 10E8 FAB LIGHT CHAIN 9606
192 5OCK 1 L Human ACPA E4 Fab fragment - Light chain the N-terminal glutamine is posttranslationally modified to pyroglutamic acid 9606
193 5OCK 2 H Human ACPA E4 Fab fragment - Heavy chain the N-terminal glutamine is posttranslationally modified to pyroglutamic acid 9606
194 5DD1 1 H ANTI-HIV ANTIBODY DH570 FAB HEAVY CHAIN 9544
195 5DD1 2 L ANTI-HIV ANTIBODY DH570 FAB LIGHT CHAIN 9544
196 5JUE 1 L light chain of UIC2 Fab 10090
197 5JUE 2 H heavy chain of UIC2 Fab 10090
198 5CIN 1 H FAB 4E10 HEAVY CHAIN 9606
199 5CIN 2 L FAB 4E10 LIGHT CHAIN 9606
200 5A2J 1 H SCFV-SM3 CONTAINS BOTH H AND L CHAINS OF SCFV-SM3, CONNECTEDBY A LINKER. CHAIN L RESIDUES ARE NUMBERED FROM 1000. RESIDUES 6-115,20-129 10090
201 5JR1 1 H 10E8 heavy chain 9606
202 5JR1 2 L 10E8 mature light chain 9606
203 6CA7 1 L PCT64_13C light chain 9606
204 6CA7 2 H PCT64_13C heavy chain 9606
205 3CFB 1 A, L BLUE FLUORESCENT ANTIBODY EP2-19G2-KAPPA LIGHT CHAIN FAB 10090
206 3CFB 2 B, H BLUE FLUORESCENT ANTIBODY EP2-19G2-IGG2B HEAVY CHAIN FAB 10090
207 3WII 1 L, M anti-human ROBO1 antibody B2212A Fab light chain 10090
208 3WII 2 H, I anti-human ROBO1 antibody B2212A Fab heavy chain 10090
209 5OB5 2 H fAb Heavy chain 9606
210 5OB5 3 L fAb Light chain 9606
211 3BKJ 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
212 3BKJ 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
213 5I66 1 A 8B6 antibody, heavy chain 10090
214 5I66 2 B 8B6 antibody, light chain 10090
215 4JAM 1 A, H ANTIGEN BINDING FRAGMENT OF HEAVY CHAIN of CH103 9606
216 4JAM 2 B, L ANTIGEN BINDING FRAGMENT OF LIGHT CHAIN of CH103 9606
217 6BZY 1 H 22D11 Heavy Chain 10090
218 6BZY 2 L 22D11 Light Chain 10090
219 3QQ9 1 C, L 101F LIGHT CHAIN 10090
220 3QQ9 2 D, H 101F HEAVY CHAIN 10090
221 5TKK 2 H mouse antibody vFP5.01 heavy chain 10090
222 5TKK 3 L mouse antibody vFP5.01 light chain 10090
223 5FGB 1 A, B Anti-HCV E2 Fab HC84-1 light chain 9606
224 5FGB 2 C, E Anti-HCV E2 Fab HC84-1 heavy chain 9606
225 5W6C 1 H UCA Fab heavy chain 9606
226 5W6C 2 L UCA Fab light chain 9606
227 5I1K 1 L FAB LIGHT CHAIN 9606
228 5I1K 2 H FAB HEAVY CHAIN 9606
229 3OZ9 1 L Fab NC-1 kappa light chain 10090
230 3OZ9 2 H Fab NC-1 IgG2a heavy chain 10090
231 4JDV 1 A, H Fab heavy chain NIH45-46 Germ-line HEAVY CHAIN, IG GAMMA-1 CHAIN 9606
232 4JDV 2 B, L Fab light chain NIH45-46 Germ-line Light CHAIN, IG Kappa 9606
233 5V7U 1 L CBTAU-22.1 Fab light chain 9606
234 5V7U 2 H CBTAU-22.1 Fab heavy chain 9606
235 5UEA 1 A, H Fab Heavy Chain 9606
236 5UEA 3 B, L Fab Light Chain 9606
237 4AL8 2 H FAB 2H12 HEAVY CHAIN 9606
238 4AL8 3 L FAB 2H12 LIGHT CHAIN 9606
239 3G5Y 1 A 175 light chain 10090
240 3G5Y 2 B 175 heavy chain 10090
241 5NMV 1 L Fab light chain 10088
242 5NMV 2 H Fab heavy chain 10088
243 4N8C 1 H, I Heavy chain of monoclonal antibody 10090
244 4N8C 2 L, M Light chain of monoclonal antibody 10090
245 5AZ2 1 H anti-human epiregulin antibody 9E5 Fab heavy chain 10090
246 5AZ2 2 L anti-human epiregulin antibody 9E5 Fab light chain 10090
247 4HGW 1 A Antibody Fab fragment, light chain 10090
248 4HGW 2 B Antibody Fab fragment, heavy chain 10090
249 1NLB 1 L antibody 19D9D6 light chain 10090
250 1NLB 2 H antibody 19D9D6 heavy chain 10090
251 1C5C 1 L CHIMERIC DECARBOXYLASE ANTIBODY 21D8 THE CONSTANT DOMAIN (RESIDUES 103-214) IS FROM HUMAN SOURCE, AND THE VARIABLE DOMAIN (RESIDUES 1-102) IS FROM MURINE SOURCE FAB 10090
252 1C5C 2 H CHIMERIC DECARBOXYLASE ANTIBODY 21D8 THE CONSTANT DOMAIN (RESIDUES 109-230) IS FROM HUMAN SOURCE, AND THE VARIABLE DOMAIN (RESIDUES 1-108) IS FROM MURINE SOURCE FAB 10090
253 3VFG 1 L 3F8 Light Chain 10090
254 3VFG 2 H 3F8 Heavy Chain 10090
255 5TDN 1 A, C anti-HER2 Fab Light Chain 9606
256 5TDN 2 B, D anti-HER2 Fab Heavy Chain 9606
257 3QRG 1 L Fab light chain 9606
258 3QRG 2 H Fab heavy chain Fd fragment 9606
259 5M6A 1 A, B, C, D Bence-Jones light chain 9606
260 4LLY 2 B, D light chain Clambda 9606
261 4EBQ 1 H anti-Vaccinia D8L antigen monoclonal IgG2a antibody LA5, heavy chain Fab 10090
262 4EBQ 2 L anti-Vaccinia D8L antigen monoclonal IgG2a antibody LA5, light chain 10090
263 5EZI 1 H Fab c12 heavy chain 9606
264 5EZI 2 L Fab c12 Light chain 9606
265 4K23 1 H anti-uPAR antibody, heavy chain 10090
266 4K23 2 L anti-uPAR antibody, light chain 10090
267 3NCJ 1 L Fab15 Mut8 light chain 9606
268 3NCJ 2 H Fab15 Mut8 heavy chain 9606
269 3UO1 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
270 3UO1 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
271 4M1G 1 L Murine IgG2a A27D7 Light chain Fab domain 10090
272 4M1G 2 H Murine IgG2a A27D7 Heavy chain Fab domain 10090
273 5W05 1 L M59 FAB LIGHT CHAIN 10090
274 5W05 2 H M59 FAB HEAVY CHAIN FD 10090
275 2IPU 1 K, L IgG2a Fab fragment Heavy Chain 10090
276 2IPU 2 G, H IgG2a Fab fragment Light Chain Kappa 10090
277 3HC3 1 H IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
278 3HC3 2 L IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
279 4M61 1 A, C Fab A52 light chain 10090
280 4M61 2 B, D Fab A52 heavy chain 10090
281 3BKM 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
282 3BKM 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
283 1UM5 1 L Antibody 21H3 L chain 10090
284 1UM5 2 H Antibody 21H3 H chain 10090
285 3QHF 1 H Human monoclonal antibody del2D1, Fab Heavy Chain Fab Heavy Chain 9606
286 3QHF 2 L Human monoclonal antibody del2D1, Fab Light Chain Fab Light Chain 9606
287 4NWT 1 L APE1531 Ab Fab light chain 9606
288 4NWT 2 H APE1531 Ab Fab heavy chain 9606
289 3WHX 1 A mAb Fab H fragment 10090
290 3WHX 2 B mAb Fab L fragment 10090
291 3NA9 1 L Fab15 light chain 9606
292 3NA9 2 H Fab15 heavy chain 9606
293 3BAE 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
294 3BAE 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
295 1NGZ 1 A Germline Metal Chelatase Catalytic Antibody, Light chain germline Fab fragment 10090
296 1NGZ 2 B Germline Metal Chelatase Catalytic Antibody, Heavy chain germline Fab fragment 10090
297 4LRI 1 A, B MSL-109 Light Chain 9606
298 4LRI 2 C, P MSL-109 Heavy Chain 9606
299 4ZTP 1 L Light chain of Fab fragment of rabbit monoclonal antibody R53 9986
300 4ZTP 2 H Heavy chain of Fab fragment of rabbit monoclonal antibody R53 9986
301 4JN2 1 A, L anti dabigatran Fab 10090
302 4JN2 2 B, H anti dabigatran Fab 10090
303 4XBE 1 L 4E10 FAB LIGHT CHAIN 9606
304 4XBE 2 H 4E10 Fab heavy chain 9606
305 1MJ8 1 L IMMUNOGLOBULIN MS6-126 Fab Fragment, LIGHT CHAIN 10090
306 1MJ8 2 H IMMUNOGLOBULIN MS6-126 Fab Fragment, HEAVY CHAIN 10090
307 6BE2 1 H Fab (F598) Heavy Chain 9606
308 6BE2 2 L Fab (F598) Light Chain 9606
309 4JFZ 1 L Fab light chain 9606
310 4JFZ 2 H Fab heavy chain 9606
311 3WIF 1 A mAb Fab H fragment 10090
312 3WIF 2 B mAb Fab L fragment 10090
313 5U6A 1 A Light Chain 9606
314 5U6A 2 B Heavy Chain 9606
315 5KVD 2 L ZV-2 Antibody Fab Light Chain 10090
316 5KVD 3 H ZV-2 Antibody Fab Heavy Chain 10090
317 3MBX 1 L X836 LIGHT CHAIN 10090
318 3MBX 2 H X836 HEAVY CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN, FD fragment 10090
319 3TWC 1 L PGT127 light chain, Ig lambda-2 chain C regions 9606
320 3TWC 2 H PGT127 heavy chain, Ig gamma-1 chain C region 9606
321 6APC 1 H Epididymis luminal protein 214 9606
322 6APC 2 L IGL@ protein 9606
323 4HHA 1 A Fab KE5 Fab fragment KE5 9606
324 4HHA 2 B Antibody KE5 AD-2S1 eptiope 9606
325 5A2K 1 H IG LAMBDA-1 CHAIN V REGION S43 RESIDUES 6-115,20-129 10090
326 4RGO 2 H 14G8 heavy chain Fab 10090
327 4RGO 3 L 14G8 light chain Fab 10090
328 5N7B 1 H Ig heavy chain V-III region J606,Ig lambda-1 chain V region S43 Please follow the numbering described in the PDB entry 5A2K 10090
329 5GRY 1 A, G diabody 9606
330 5UEK 2 H Fab 12E Heavy Chain 9606
331 5UEK 3 L Fab 12E Light Chain 9606
332 3NAA 1 L Fab15 Mut5 light chain 9606
333 3NAA 2 H Fab15 Mut5 heavy chain 9606
334 1Q0X 1 L Fab 9B1, light chain 10090
335 1Q0X 2 H Fab 9B1, heavy chain 10090
336 4R90 1 L Anti CD70 Llama glama Fab 27B3 Light chain 9844
337 4R90 2 H Anti CD70 Llama glama Fab 27B3 Heavy chain 9844
338 4XVT 2 H donor 45 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 (VRC07_1995) Heavy chain 9606
339 4XVT 3 L 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 (VRC07_1995) Light chain 9606
340 5IK3 1 A, C 1E03 Fab fragment heavy chain 9606
341 5IK3 2 B, D 1E03 Fab fragment light chain 9606
342 5NPH 2 H Heavy chain of Fab fragment derived from non-neutralizing antibody DAO5 10090
343 5NPH 3 L Light chain of Fab fragment derived from non-neutralizing antibody DAO5 10090
344 5XLI 1 a, b FabL 10090
345 5XLI 2 c, d FabH 10090
346 5IHZ 1 A, C, E, H 1E01 Fab fragment heavy chain 9606
347 5IHZ 2 B, D, F, L 1E01 Fab fragment light chain 9606
348 2R1X 1 A Fab, antibody fragment (IgG1k), light chain 10090
349 2R1X 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
350 5U3D 1 A MEMAB TRASTUZUMAB FAB LIGHT CHAIN I83E 9606
351 5U3D 2 B MEMAB TRASTUZUMAB FAB HEAVY CHAIN 9606
352 4WUK 1 H CH65 heavy chain 9606
353 4WUK 2 L CH65 light chain 9606
354 3MLY 1 L, M Human monoclonal anti-HIV-1 gp120 V3 antibody 3074 Fab light chain 9606
355 3MLY 2 H, I Human monoclonal anti-HIV-1 gp120 V3 antibody 3074 Fab heavy chain 9606
356 5U3O 1 H DH511.2_K3 Fab Heavy Chain 9606
357 5U3O 2 L DH511.2_K3 Fab Light Chain 9606
358 5JOP 1 D, L Fab 14.22 light chain 10090
359 5JOP 2 E, H Fab14.22 heavy chain 10090
360 4HPO 1 H CH58 Fab heavy chain 9606
361 4HPO 2 L CH58 Fab light chain 9606
362 5UKN 1 H DH522UCA Fab fragment heavy chain 9544
363 5UKN 2 L DH522UCA Fab fragment light chain 9544
364 6BHZ 1 H, I Trastuzumab Anti-HER2 Fab Heavy Chain 9606
365 6BHZ 2 L, M Trastuzumab Anti-HER2 Fab Light Chain D185A 9606
366 5IT2 1 H heavy chain 9606
367 5IT2 2 L light chain 9606
368 4POZ 1 C light chain of Fab fragment of 10B9 antibody 10090
369 4POZ 2 D heavy chain of Fab fragment of 10B9 antibody 10090
370 4F57 1 L Light chain of Fab of a neutralizing antibody L1 light chain of L1 9606
371 4F57 2 H Heavy chain of Fab of a neutralizing antibody L1 heavy chain of L1 9606
372 5MO3 2 H Fab of monoclonal antibody, heavy chain 10090
373 5MO3 3 L Fab of monoclonal antibody, light chain 10090
374 5GZ0 1 A, C FM329 light chain 1383439
375 5GZ0 2 B, D FM329 heavy chain 1383439
376 6BQB 1 L MGG4 Fab light chain 9606
377 6BQB 2 H MGG4 Fab heavy chain 9606
378 4PUB 1 H DX-2930 HEAVY CHAIN 9606
379 4PUB 2 L DX-2930 LIGHT CHAIN 9606
380 6B14 1 H Heavy chain of Fab BL3-6S97N 10090
381 6B14 2 L Light chain of Fab BL3-6S97N 10090
382 5DD6 1 A, H ANTI-HIV ANTIBODY DH570.mut58 FAB HEAVY CHAIN 9544
383 5DD6 2 B, L ANTI-HIV ANTIBODY DH570.mut58 FAB LIGHT CHAIN 9544
384 3WIH 2 L, M anti-human ROBO1 antibody B2212A Fab light chain 10090
385 3WIH 3 H, I anti-human ROBO1 antibody B2212A Fab heavy chain 10090
386 5GS3 1 A, H diabody protein 9606
387 3CFC 1 H BLUE FLUORESCENT ANTIBODY EP2-19G2-IGG2B HEAVY CHAIN FAB 10090
388 3CFC 2 L BLUE FLUORESCENT ANTIBODY EP2-19G2-KAPPA LIGHT CHAIN FAB 10090
389 3V4U 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
390 3V4U 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
391 5VKD 2 H Fab Heavy Chain 9606
392 5VKD 3 L Fab light chain 9606
393 2R1Y 1 A Fab, antibody fragment (IgG1k), light chain 10090
394 2R1Y 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
395 5XHG 1 A, C polypeptide(L) 562
396 5XHG 2 B, D polypeptide(H) 562
397 4XMP 2 H HEAVY CHAIN OF ANTIBODY VRC08 9606
398 4XMP 3 L LIGHT CHAIN OF ANTIBODY VRC08 9606
399 3UYR 1 H antibody Fab heavy chain 10090
400 3UYR 2 L antibody Fab light chain 10090
401 3V0W 1 L WN1 222-5 Fab (IgG2a) light chain 10090
402 3V0W 2 H WN1 222-5 Fab (IgG2a) heavy chain 10090
403 5OCX 1 L Fab fragment anti-citrullinated protein antibody E4 - light chain N-terminal glutamine is posttranslationally modified to pyroglutamic acid produced as chimera of human E4 mAb variable domains and mouse IgG2a constant domains 9606
404 5OCX 2 H Fab fragment of anti-citrullinated protein antibody E4 - heavy chain unmodelled residues not visible in electron density produced as chimera of human mAb E4 variable domains and mouse IgG2a constant domains 9606
405 1YQV 1 L HyHEL-5 Antibody Light Chain IG*G1 FAB FRAGMENT (HY/HEL-5) 10090
406 1YQV 2 H HyHEL-5 Antibody Heavy Chain IG*G1 FAB FRAGMENT (HY/HEL-5) 10090
407 3OAZ 1 H, M Fab 2G12, heavy chain Fab 9606
408 3OAZ 2 K, L Fab 2G12, light chain 9606
409 2R2B 1 A Fab, antibody fragment (IgG1k), light chain 10090
410 2R2B 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
411 1ZAN 1 L Fab AD11 Light Chain 10116
412 1ZAN 2 H Fab AD11 Heavy Chain 10116
413 4N0Y 1 H IGH526 Heavy Chain 9606
414 4N0Y 2 L IGH526 Light Chain 9606
415 3V52 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
416 3V52 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
417 5MTH 1 A, H antibody Fab heavy chain 10090
418 5MTH 2 B, L antibody Fab light chain 10090
419 3GGW 1 A, C FAB F22-4 LIGHT CHAIN 10090
420 3GGW 2 B, D FAB F22-4 HEAVY CHAIN 10090
421 1RZF 1 L Fab E51 light chain 9606
422 1RZF 2 H Fab E51 heavy chain 9606
423 4KTE 1 H GE148 Heavy Chain Fab Fab fragment 9544
424 4KTE 2 L GE148 Light Chain Fab 9544
425 5I8O 1 H HMM5 antibody heavy chain 9606
426 5I8O 2 L HMM5 antibody light chain 9606
427 4JG0 1 L Fab light chain 9606
428 4JG0 2 H Fab heavy chain 9606
429 4YGV 1 A, F aDabi-Fab2a heavy chain 9606
430 4YGV 2 B, L aDabi-Fab2a light chain 9606
431 5U4R 1 A, H VRC 315 53-1A09 Fab Heavy chain 9606
432 5U4R 2 B, L VRC 315 53-1A09 Fab Light chain 9606
433 5ALC 1 H ANTI-TICAGRELOR FAB 72, HEAVY CHAIN 9606
434 5ALC 2 L ANTI-TICAGRELOR FAB 72, LIGHT CHAIN 9606
435 5U5F 1 A MEMAB TRASTUZUMAB FAB LIGHT CHAIN I83E 9606
436 5U5F 2 B MEMAB TRASTUZUMAB FAB HEAVY CHAIN 9606
437 3EO0 1 A, C GC-1008 Fab Light Chain 10090
438 3EO0 2 B, D GC-1008 Fab Heavy Chain 10090
439 5CIL 1 H FAB 4E10 HEAVY CHAIN 9606
440 5CIL 2 L FAB 4E10 LIGHT CHAIN 9606
441 6BI2 1 H, I Trastuzumab Anti-HER2 Fab Heavy Chain 9606
442 6BI2 2 L, M Trastuzumab Anti-HER2 Fab Light Chain 9606
443 5F3B 1 A, E RK35 Chimeric antibody heavy chain 10090
444 5F3B 2 B, F RK35 Chimeric antibody light chain 10090
445 4FQI 3 H antibody CR9114 heavy chain Fab 9606
446 4FQI 4 L antibody CR9114 light chain Fab Lambda 9606
447 4JHA 1 H D25 antigen-binding fragment heavy chain 9606
448 4JHA 2 L D25 light chain 9606
449 3MCL 1 L C706 MONOCLONAL LIGHT CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090
450 3MCL 2 H C706 MONOCLONAL HEAVY CHAIN FD fragment of the heavy chain, CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090
451 4PTT 1 A Antibody pn132p2C05, light chain 9606
452 4PTT 2 B Antibody pn132p2C05, heavy chain 9606
453 5OD0 1 L Fab fragment of ACPA E4 - Light chain the Fab fragment was prepared from a chimeric antibody containing the variable domain of human ACPA E4 and constant domains of mouse IgG2b the N-terminal Gln is posttranslationally modified to pyroglutamic acid 2 C-terminal residues not visible in electron density and therefore not modelled 9606
454 5OD0 2 H Fab fragment of ACPA E4 - heavy chain the Fab fragment was prepared from a chimeric antibody containing the variable domain of human ACPA E4 and constant domains of mouse IgG2b the N-terminal Gln is posttranslationally modified to pyroglutamic acid residues not modeled are not visible in the electron density map 9606
455 5KVL 1 H Humanized 10G4 anti-Leukotriene C4 Immunoglobulin G (IgG) heavy chain Fab fragment 9606
456 5KVL 2 L Humanized 10G4 anti-Leukotriene C4 Immunoglobulin G (IgG) light chain 9606
457 5TDO 1 A, C anti-HER2 Fab Light Chain 9606
458 5TDO 2 B, D anti-HER2 Fab Heavy Chain 9606
459 8FAB 1 A, C IGG1-LAMBDA HIL FAB (LIGHT CHAIN) 9606
460 8FAB 2 B, D IGG1-LAMBDA HIL FAB (HEAVY CHAIN) 9606
461 5NHW 1 H anti-human ActRII Bimagrumab Fab heavy-chain C-terminal FLAG-His6 tag Fab heavy-chain 9606
462 5NHW 2 L anti-human ActRII Bimagrumab Fab light-chain Fab light-chain 9606
463 2ZPK 1 L, M IgG1-lambda P20.1 Fab (light chain) 10090
464 2ZPK 2 H, I IgG1-lambda P20.1 Fab (heavy chain) Variable and Constant region 10090
465 4DGV 1 H HCV1 Heavy Chain Fab 9606
466 4DGV 2 L HCV1 Light Chain 9606
467 2DQU 1 L IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
468 2DQU 2 H IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
469 5TH2 1 A, C cetuximab Fab, light chain 10090
470 5TH2 2 B, D cetuximab Fab, heavy chain 10090
471 5I8K 1 L HHH1 Fab Light chain 9606
472 5I8K 2 H HHH1 Fab Heavy chain 9606
473 4YDL 2 B, H HEAVY CHAIN OF ANTIBODY C38-VRC18.02 9606
474 4YDL 3 C, L LIGHT CHAIN OF ANTIBODY C38-VRC18.02 9606
475 3T4Y 1 A S25-2 FAB (IGG1K) LIGHT CHAIN 10090
476 3T4Y 2 B S25-2 FAB (IGG1K) HEAVY CHAIN 10090
477 1YNL 1 L Ig gamma light chain 10090
478 1YNL 2 H Ig gamma heavy chain 10090
479 5EPM 1 A, E Antibody Fab fragment heavy chain 10090
480 5EPM 2 B, F Antibody Fab fragment light chain 10090
481 2AJS 1 L Antibody 7A1 FAB' IMMUNOGLOBULIN IGG1 kappa light chain 10090
482 2AJS 2 H Antibody 7A1 FAB' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
483 3UMT 1 A scFv heavy chain and light chain 10090
484 3BZ4 1 A, C, E, G Fab F22-4 light chain 10090
485 3BZ4 2 B, D, F, H Fab F22-4 heavy chain 10090
486 4NUJ 1 A PGT152 light chain 9606
487 4NUJ 2 B PGT152 heavy chain 9606
488 3LIZ 2 L 4C3 monoclonal antibody Light Chain 10090
489 3LIZ 3 H 4C3 monoclonal antibody Heavy Chain 10090
490 1RUA 1 L immunoglobulin igg2a, light chain fab 10090
491 1RUA 2 H immunoglobulin igg2a, heavy chain fab 10090
492 3U2S 1 A, H PG9 heavy chain antigen-binding fragment 9606
493 3U2S 2 B, L PG9 light chain 9606
494 5D6C 1 A, L 4497 antibody IgK (VL and CL) 9606
495 5D6C 2 B, H 4497 antibody IgG1 (VH and CH1) 9606
496 4GAG 1 H NEUTRALIZING ANTIBODY AP33 HEAVY CHAIN 10090
497 4GAG 2 L NEUTRALIZING ANTIBODY AP33 LIGHT CHAIN 10090
498 2R23 1 A Fab, antibody fragment (IgG1k), light chain 10090
499 2R23 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
500 4NUG 1 L PGT151 light chain 9606
501 4NUG 2 H PGT151 heavy chain 9606
502 3IU4 1 H chP3 Fab heavy chain 10090
503 3IU4 2 L chP3 Fab light chain 10090
504 3MNZ 2 A ANTI-HIV-1 ANTIBODY 13H11 LIGHT CHAIN mouse Fv,human Fc 10090
505 3MNZ 3 B ANTI-HIV-1 ANTIBODY 13H11 HEAVY CHAIN mouse Fv,human Fc 10090
506 3MLR 1 L Human monoclonal anti-HIV-1 gp120 V3 antibody 2557 Fab light chain 9606
507 3MLR 2 H Human monoclonal anti-HIV-1 gp120 V3 antibody 2557 Fab heavy chain 9606
508 1QYG 1 L FAB M82G2, LIGHT CHAIN 10090
509 1QYG 2 H FAB M82G2, HEAVY CHAIN 10090
510 1P7K 1 A, L antibody light chain FAB 10090
511 1P7K 2 B, H antibody heavy chain FAB 10090
512 3RVV 2 C 4C1 - light chain 10090
513 3RVV 3 D 4C1 - heavy chain 10090
514 5A2L 1 H SCFV-SM3 RESIDUES 6-115,20-129 10090
515 3P0Y 2 H Fab DL11 heavy chain 9606
516 3P0Y 3 L Fab DL11 light chain 9606
517 4NPY 1 A, L germline PGT121 light chain Fab 9606
518 4NPY 2 B, H germline PGT121 heavy chain Fab 9606
519 6ANA 2 H LL2 Fab Heavy Chain 10090
520 6ANA 3 L LL2 Fab Light Chain 10090
521 5IBU 1 B, L 6652 Light Chain 9606
522 5IBU 2 G, H 6652 Heavy Chain 9606
523 5VPL 2 C 4C1 - LIGHT CHAIN 10090
524 5VPL 3 D 4C1 - HEAVY CHAIN 10090
525 6AOD 1 A FXIa Antibody FAB Light Chain 9606
526 6AOD 2 B FXIa Antibody FAB Heavy Chain 9606
527 5WCD 1 H VRC315 04-1D02 Fab Heavy chain 9606
528 5WCD 2 L VRC315 04-1D02 Fab Light chain 9606
529 2YPV 2 H FAB 12C1 10090
530 2YPV 3 L FAB 12C1 10090
531 4HH9 1 A, C Fab KE5, light chain KE5 Light chain 9606
532 4HH9 2 B, D Fab KE5, heavy chain KE5 Heavy Chain 9606
533 4JY5 1 L PGT122 light chain Fab 9606
534 4JY5 2 H PGT122 heavy chain Fab 9606
535 6ELE 1 A, H fAB heavy chain 9606
536 6ELE 2 B, L fAB light chain 9606
537 5UR8 1 A human immunoglobulin gamma, heavy chain Fd fragment 9606
538 5UR8 2 B human immunoglobulin gamma, kappa light chain 9606
539 6B5R 1 H CIS42 Fab Heavy chain 9606
540 6B5R 2 L CIS42 Fab Light chain 9606
541 3NAC 1 L Fab15 Mut7 light chain 9606
542 3NAC 2 H Fab15 Mut7 heavy chain 9606
543 5U5M 1 A MEMAB TRASTUZUMAB, LIGHT CHAIN 9606
544 5U5M 2 B MEMAB TRASTUZUMAB, HEAVY CHAIN 9606
545 2DQT 1 L IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
546 2DQT 2 H IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
547 1Q72 1 L Fab M82G2, Light chain 10090
548 1Q72 2 H Fab M82G2, Heavy chain 10090
549 4M1D 1 L, M Fab mAb 447-52D Light Chain 9606
550 4M1D 2 H, I Fab mAb 447-52D Heavy Chain 9606
551 1SEQ 1 L Monoclonal Antibody MNAC13 FAB Light Chain 10090
552 1SEQ 2 H Monoclonal Antibody MNAC13 FAB Heavy Chain 10090
553 4YHO 1 H aDabi-Fab3 heavy chain 9606
554 4YHO 2 L aDabi-Fab3 light chain 9606
555 2R1W 1 A Fab, antibody fragment (IgG1k), light chain 10090
556 2R1W 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
557 3MO1 1 A ANTI-HIV-1 ANTIBODY 13H11 LIGHT CHAIN FUSION PROTEIN between mouse Fv and a human Fc 10090
558 3MO1 2 B ANTI-HIV-1 ANTIBODY 13H11 HEAVY CHAIN FUSION PROTEIN between mouse Fv and a human Fc 10090
559 4DGY 1 H HCV1 Heavy Chain Fab 9606
560 4DGY 2 L HCV1 Light Chain 9606
561 5EN2 1 A GD01 heavy chain 10090
562 5EN2 2 B GD01 light chain 10090
563 3T77 1 A S25-2 FAB (IGG1K) light chain 10090
564 3T77 2 B S25-2 FAB (IGG1K) heavy chain 10090
565 3MXW 2 L 5E1 light chain 9606
566 3MXW 3 H 5E1 heavy chain 9606
567 2V7N 1 A, C, E, G IMMUNOGLOBULIN LIGHT CHAIN SYNTHETIC GENE, DERIVED FROM PHAGE DISPLAY OF THE HUMAN COMBINATORIAL ANTIBODY LIBRARY (HUCAL) FAB FRAGMENT, RESIDUES 1-255 32630
568 2V7N 2 B, D, F, H IMMUNOGLOBULIN HEAVY CHAIN SYNTHETIC GENE, DERIVED FROM PHAGE DISPLAY OF THE HUMAN COMBINATORIAL ANTIBODY LIBRARY (HUCAL) FAB FRAGMENT, RESIDUES 1-259 32630
569 3EO9 1 L Efalizumab Fab fragment, light chain 9606
570 3EO9 2 H Efalizumab Fab fragment, heavy chain 9606
571 4ALA 2 H FAB 2H12 HEAVY CHAIN 10090
572 4ALA 3 L FAB 2H12 LIGHT CHAIN 10090
573 4F33 1 A, C, E, G MORAb-009 FAB light chain 10090
574 4F33 2 B, D, F, H MORAb-009 FAB heavy chain 10090
575 3C6S 1 A, C, E, G Fab F22-4 light chain 10090
576 3C6S 2 B, D, F, H Fab F22-4 heavy chain 10090
577 5WUV 1 L light chain 9606
578 5WUV 2 H heavy chain 9606
579 4Z8F 1 H S1-15 Fab (IgG2b) heavy chain 10090
580 4Z8F 2 L S1-15 Fab (IgG2b kappa) light chain 10090
581 3OKL 1 A S25-39 Fab (IgG1k) light chain 10090
582 3OKL 2 B S25-39 Fab (IgG1k) heavy chain 10090
583 4JM4 1 H PGT 135 Heavy Chain Fab 9606
584 4JM4 2 L PGT 135 Light Chain Fab 9606
585 2HWZ 1 L Immunoglobulin Fab light chain Humanized mouse antibody MEDI-493 Anti-respiratory syncytial virus antibody 10090
586 2HWZ 2 H Immunoglobulin Fab heavy chain Humanized mouse antibody MEDI-493 Anti-respiratory syncytial virus antibody 10090
587 6B0G 1 C 1245 Antibody, Light Chain 9606
588 6B0G 2 D 1245 Antibody, Heavy Chain 9606
589 5TDP 1 A, C anti-HER2 Fab Light Chain 9606
590 5TDP 2 B, D anti-HER2 Fab Heavy Chain 9606
591 1ZEA 1 L monoclonal anti-cholera toxin IGG1 KAPPA antibody, L chain 10090
592 1ZEA 2 H monoclonal anti-cholera toxin IGG1 KAPPA antibody, H chain 10090
593 6D0X 1 A 2140 Antibody, heavy chain 9606
594 6D0X 2 B 1210 Antibody, light chain 9606
595 6BE4 1 H Fab (F598) Heavy Chain 9606
596 6BE4 2 L Fab(F598) Light Chain 9606
597 5TPP 1 L DH270.5 Fab heavy chain 9606
598 5TPP 2 H DH270.5 Fab light chain 9606
599 5L88 1 H Anti-afamin antibody N14, Fab fragment, heavy chain 10090
600 5L88 2 L Anti-afamin antibody N14, Fab fragment, light chain 10090
601 1Q9W 1 A, C S45-18 Fab (IgG1k) light chain Fab1 Light chain kappa 10090
602 1Q9W 2 B, D S45-18 Fab (IgG1k) heavy chain Fab1 Heavy chain g1 10090
603 4P3C 1 H Heavy Chain Fab fragment of antibody LEM-2/15 MT1-MMP V-B loop 10090
604 4P3C 2 L Light Chain Fab fragment of antibody LEM-2/15 10090
605 1L7I 1 L chimera of Fab2C4: "humanized" murine monoclonal antibody The chimera consists of the human Ig and the original murine sequence light chain (residues 1-214) 9606
606 1L7I 2 H chimera of Fab2C4: "humanized" murine monoclonal antibody The chimera consists of the human Ig and the original murine sequence heavy chain (residues 1-216) 9606
607 1JPT 1 L immunoglobulin Fab D3h44, light chain Fab fragment 9606
608 1JPT 2 H immunoglobulin Fab D3H44, heavy chain Fab fragment 9606
609 1AQK 1 L FAB B7-15A2 IMMUNOGLOBULIN HUMAN FAB FAB 9606
610 1AQK 2 H FAB B7-15A2 IMMUNOGLOBULIN HUMAN FAB FAB 9606
611 5TL5 1 L M2177 LIGHT CHAIN 10090
612 5TL5 2 H M2177 HEAVY CHAIN 10090
613 2FX7 1 L Fab 4E10 Light Chain 9606
614 2FX7 2 H Fab 4E10 Heavy Chain 9606
615 5Y9K 1 L belimumab light chain 9606
616 5Y9K 2 H belimumab heavy chain 9606
617 4DTG 1 L Humanized recombinant FAB fragment, FAB 2021, of a murine antibody, light chain 9606
618 4DTG 2 H Humanized recombinant FAB fragment, FAB 2021, of a murine antibody, heavy chain 9606
619 5CSZ 1 A, H GANTENERUMAB FAB FRAGMENT HEAVY CHAIN FAB 9606
620 5CSZ 2 B, L GANTENERUMAB FAB FRAGMENT LIGHT CHAIN FAB 9606
621 3WFH 1 A mAb Fab H fragment 10090
622 3WFH 2 B mAb Fab L fragment 10090
623 4K3D 1 H, I BOVINE ANTIBODY WITH ULTRALONG CDR H3, HEAVY CHAIN 9913
624 4K3D 2 L, M BOVINE ANTIBODY WITH ULTRALONG CDR H3, LIGHT CHAIN 9913
625 4H8W 2 H FAB HEAVY CHAIN OF ADCC AND NON-NEUTRALIZING ANTI-HIV-1 ANTIBODY N5-I5 9606
626 4H8W 3 L FAB LIGHT CHAIN OF ADCC AND NON-NEUTRALIZING ANTI-HIV-1 ANTIBODY N5-I5 9606
627 3HNT 1 H CS-35 Fab Heavy Chain Heavy Chain 10090
628 3HNT 2 L CS-35 Fab Light Chain Light Chain 10090
629 1WEJ 1 L E8 ANTIBODY IGG1 KAPPA MOUSE MONOCLONAL ANTIBODY FAB 10090
630 1WEJ 2 H E8 ANTIBODY IGG1 KAPPA MOUSE MONOCLONAL ANTIBODY FAB 10090
631 5VPG 2 C FAB 4C1 - LIGHT CHAIN 10090
632 5VPG 3 D FAB 4C1 - HEAVY CHAIN 10090
633 5HI4 2 C, H CAT-2000 FAB heavy chain 9606
634 5HI4 3 D, L CAT-2000 FAB light chain 9606
635 5NUZ 1 A, H eOD01 heavy chain Fab fragment (domains: variable heavy and constant heavy 1) Fab fragment (domains: variable heavy and constant heavy 1) 10090
636 5NUZ 2 B, L eOD01 light chain Fab fragment (domains: variable light and constant light) Fab fragment (domains: variable light and constant light) 10090
637 5FCU 2 H JR4 FAB HEAVY CHAIN 9544
638 5FCU 3 L JR4 FAB LIGHT CHAIN 9544
639 3RVW 2 C 4C1 - light chain 10090
640 3RVW 3 D 4C1 - heavy chain 10090
641 5DD3 1 H ANTI-HIV ANTIBODY DH570.4 FAB HEAVY CHAIN 9544
642 5DD3 2 L ANTI-HIV ANTIBODY DH570.4 FAB LIGHT CHAIN 9544
643 5XKU 2 B HNIgGA6 light chain 9606
644 5XKU 3 C HNIgGA6 heavy chain 9606
645 3D85 1 A FAB of antibody 7G10, light chain light chain 9606
646 3D85 2 B FAB of antibody 7G10, heavy chain heavy chain 9606
647 4Z95 1 H S1-15 Fab (IgG2b) heavy chain 10090
648 4Z95 2 L S1-15 Fab (IgG2b) light chain 10090
649 5HI5 2 C, H CAT-2000 FAB heavy chain 9606
650 5HI5 3 D, L CAT-2000 light chain 9606
651 5JO5 1 A, C, E, H 10E8 gHV 9606
652 5JO5 2 B, D, F, L 10E8 gLV 9606
653 5L9D 1 H MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA HEAVY CHAIN 10090
654 5L9D 2 L MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA LIGHT CHAIN 10090
655 5CCK 1 H Antibody 3BC315 Fab heavy chain 9606
656 5CCK 2 L Antibody 3BC315 Fab light chain 9606
657 5I76 1 A, C FM318_light_chain 1383439
658 5I76 2 B, D FM318_heavy_cahin 1383439
659 1KCV 1 L PC282 IMMUNOGLOBULIN light chain 10090
660 1KCV 2 H PC282 IMMUNOGLOBULIN heavy chain 10090
661 1FLR 1 L 4-4-20 (IG*G2A=KAPPA=) FAB FRAGMENT 10090
662 1FLR 2 H 4-4-20 (IG*G2A=KAPPA=) FAB FRAGMENT 10090
663 5I18 1 L FAB LIGHT CHAIN 9606
664 5I18 2 H FAB HEAVY CHAIN 9606
665 4JN1 1 H anti-dabigatran Fab1, heavy chain 10090
666 4JN1 2 L anti-dabigatran Fab1, light chain 10090
667 4P3D 1 A, H Heavy Chain Fab fragment of antibody LEM-2/15 10090
668 4P3D 2 B, L Light Chain Fab fragment of antibody LEM-2/15 10090
669 4G5Z 1 H canakinumab antibody fragment heavy chain 9606
670 4G5Z 2 L canakinumab antibody fragment light chain 9606
671 3TNM 1 A, H Fab heavy chain of human anti-HIV-1 Env antibody A32 9606
672 3TNM 2 B, L Fab light chain of human anti-HIV-1 Env antibody A32 9606
673 2OK0 2 L Fab ED10 light chain 10090
674 2OK0 3 H Fab ED10 heavy chain 10090
675 3SOB 1 L antibody light chain 9606
676 3SOB 3 H antibody heavy chain 9606
677 6B5M 1 H CIS43 Fab Heavy chain 9606
678 6B5M 2 L CIS43 Fab Light chain 9606
679 5AWN 1 H Heavy chain of 3BC176 Fab 9606
680 5AWN 2 L Light chain of 3BC176 Fab 9606
681 4ZFO 2 L J22.9-xi Fab, Light Chain Fab Light Chain fragment of anti-BCMA antibody J22.9-xi 10090
682 4ZFO 3 A, H J22.9-xi Fab, Heavy Chain Fab Heavy Chain fragment of anti-BCMA antibody J22.9-xi 10090
683 4ZFO 4 B J22.9-xi Fab, Light Chain Fab Light Chain fragment of anti-BCMA antibody J22.9-xi 10090
684 4G6M 2 H heavy chain of gevokizumab antibody binding fragment 10090
685 4G6M 3 L light chain of gevokizumab antibody binding fragment 10090
686 5DR5 1 H AbD09097 Fab heavy chain The Fab heavy chain contains a C-terminal Myc- and hexahistidine extension preceded by thrombin peptidase recognition sequence to facilitate detection and purification 9606
687 5DR5 2 L AbD09097 Fab light chain 9606
688 2IH3 1 A FAB Heavy Chain 10090
689 2IH3 2 B FAB Light Chain 10090
690 4KQ3 1 L CNTO3186 light chain Fab 9606
691 4KQ3 2 H CNTO3186 heavy chain Fab 9606
692 6AQ7 2 H POM6 FAB Heavy CHAIN 10090
693 6AQ7 3 L POM6 FAB light CHAIN 10090
694 4JFX 1 A, L Fab light chain 9606
695 4JFX 2 B, H Fab heavy chain 9606
696 3SGE 1 I, L Light Chain 10090
697 3SGE 2 H, J Heavy Chain 10090
698 1BM3 1 L IMMUNOGLOBULIN OPG2 FAB, CONSTANT DOMAIN CONSTANT DOMAIN 10090
699 1BM3 2 H IMMUNOGLOBULIN OPG2 FAB, VARIABLE DOMAIN VARIABLE DOMAIN 10090
700 4TUJ 1 A, C Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
701 4TUJ 2 B, D Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
702 2VXQ 2 H FAB H CHAIN OF THE FAB FRAGMENT COMPOSED OF THE IGE VARIABLE DOMAIN AND IGG CONSTANT DOMAIN 9606
703 2VXQ 3 L FAB L CHAIN OF THE FAB FRAGMENT COMPOSED OF THE IGE VARIABLE DOMAIN AND IGG CONSTANT DOMAIN 9606
704 2XWT 1 A THYROID BLOCKING HUMAN AUTOANTIBODY K1-70 HEAVY CHAIN FAB FRAGMENT HEAVY CHAIN, RESIDUES 1-229 9606
705 2XWT 2 B THYROID BLOCKING HUMAN AUTOANTIBODY K1-70 LIGHT CHAIN FAB FRAGMENT LIGHT CHAIN, RESIDUES 1-213 9606
706 5FHB 1 H Antibody 100 Fab heavy chain 9606
707 5FHB 2 L Antibody 100 Fab light chain 9606
708 3HZM 1 A S73-2 Fab (IgG1k) light chain 10090
709 3HZM 2 B S73-2 Fab (IgG1k) heavy chain 10090
710 1JGU 1 L Antibody Light Chain 10090
711 1JGU 2 H Antibody Heavy Chain 10090
712 4I77 1 H Lebrikizumab heavy chain Fab 9606
713 4I77 2 L Lebrikizumab light chain Fab 9606
714 4OCR 1 L CAP256-VRC26.01 light chain Fab 9606
715 4OCR 2 H CAP256-VRC26.01 heavy chain Fab 9606
716 4O4Y 1 L 2095-2 light chain SEE REMARK 999 9986
717 4O4Y 2 H 2095-2 heavy chain 9986
718 5OBF 1 H fAb Heavy chain 10090
719 5OBF 2 L fAb Light chain 10090
720 5LGH 1 H MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA HEAVY CHAIN IGG1-KAPPA HEAVY CHAIN, 1-214 10090
721 5LGH 2 L MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA LIGHT CHAIN IGG1-KAPPA LIGHT CHAIN, 1-214 10090
722 1UZ8 1 A, L IGG FAB (IGG3, KAPPA) LIGHT CHAIN 291-2G3-A FAB FRAGMENT LIGHT CHAIN, RESIDUES 1-212 10090
723 1UZ8 2 B, H IGG FAB (IGG3, KAPPA) HEAVY CHAIN 291-2G3-A FAB FRAGMENT HEAVY CHAIN, RESIDUES 1-213 10090
724 1DQQ 1 A, C ANTI-LYSOZYME ANTIBODY HYHEL-63 (LIGHT CHAIN) FAB FRAGMENT 10090
725 1DQQ 2 B, D ANTI-LYSOZYME ANTIBODY HYHEL-63 (HEAVY CHAIN) FAB FRAGMENT 10090
726 5L7X 1 H Mouse Antibody Fab Fragment, IgG1-kappa Heavy Chain IgG1-kappa heavy chain, 1-214 10090
727 5L7X 2 L Mouse Antibody Fab Fragment, IgG1-kappa Light Chain IgG1-kappa light chain, 1-214 10090
728 5V6M 1 L Light chain of Fab fragment of rabbit anti-HIV1 gp120 V3 mAb 10A3 9986
729 5V6M 2 H Heavy chain of Fab fragment of rabbit anti-HIV1 gp120 V3 mAb 10A3 9986
730 4GLR 2 H, J anti-ptau heavy chain heavy chain 9031
731 4GLR 3 I, K anti-ptau light chain light chain 9031
732 5WK3 1 P, R, T, V M116 LIGHT CHAIN 9606
733 5WK3 2 Q, S, U, W M116 HEAVY CHAIN FD 9606
734 4HJG 1 A Trastuzumab light chain 9606
735 4HJG 2 B Trastuzumab heavy chain 9606
736 5OWP 1 H Ig heavy chain V-III region J606,Ig lambda-1 chain V region H2020 10090
737 4M43 1 L Fragment antigen-binding 523-11 light chain 10090
738 4M43 2 H Fragment antigen-binding 523-11 heavy chain 10090
739 5I30 1 L Fab PL-2 light chain 10090
740 5I30 2 H Fab PL-2 heavy chain 10090
741 3HC0 1 A, H IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
742 3HC0 2 B, L IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
743 3BKC 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
744 3BKC 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
745 3FN0 1 L Fab Z13e1 light chain 9606
746 3FN0 2 H Fab Z13e1 heavy chain 9606
747 5X5X 1 H Fd chain of anti-osteocalcin antibody KTM219 10090
748 5X5X 2 L L chain of anti-osteocalcin antibody KTM219 10090
749 4YHI 1 A, H aDabi-Fab2a heavy chain 9606
750 4YHI 2 B, L aDabi-Fab2a light chain 9606
751 5NYX 1 H, M, O HEAVY CHAIN CHAIN H AND O ARE TWO SEPARATE POLYPEPTIDE CHAINS. fab heavy chains. The sequence provided contains the cleavable strep tag that has been removed prior to crystallisation 9606
752 5NYX 2 L, N, P LIGHT CHAIN fab light chain 9606
753 4OSU 1 H SM5-1 Fab Heavy Chain 9606
754 4OSU 2 L SM5-1 Fab Light Chain 9606
755 3MXV 1 L fab fragment of anti-Shh 5E1 mouse/human chimera, light chain 10090
756 3MXV 2 H fab fragment of anti-Shh 5E1 mouse/human chimera, heavy chain 10090
757 5IFA 1 H VRC01c-HuGL2 Fab heavy chain 9606
758 5IFA 2 L VRC01c-HuGL2 Fab light chain 9606
759 1T2Q 1 L Fab NNA7 Heavy Chain 10090
760 1T2Q 2 H Fab NNA7 Light Chain 10090
761 6ELJ 1 A, H fAB heavy chain 9606
762 6ELJ 2 B, L fAB light chain 9606
763 4G6K 1 H heavy chain of gevokizumab antibody binding fragment 10090
764 4G6K 2 L light chain of gevokizumab antibody binding fragment 10090
765 4MAU 1 L C2244 light chain SEE REMARK 999 10090
766 4MAU 2 H C2244 heavy chain FD, SEE REMARK 999 10090
767 3LEX 1 A, H 11f10 Antibody Heavy Chain 10090
768 3LEX 2 B, L 11f10 Antibody Light Chain 10090
769 6B0W 1 L 1710 antibody, light chain 9606
770 6B0W 2 H 1710 antibody, heavy chain 9606
771 1OP3 1 K, L FAB 2G12, light chain light chain 9606
772 1OP3 2 H, M FAB 2G12, heavy chain heavy chain 9606
773 5VH4 1 A, H Infliximab Fab Heavy Chain 10090
774 5VH4 2 B, L Infliximab Fab Light Chain 10090
775 5DQD 1 L S55-5 Fab (IgG1 kappa) light chain 10090
776 5DQD 2 H S55-5 Fab (IgG1) heavy chain 10090
777 5DT1 1 H Fab Heavy chain of broadly neutralizing antibody VRC26.25 9606
778 5DT1 2 L Fab Light chain of broadly neutralizing antibody VRC26.25 9606
779 4ONF 1 H 3D6 FAB ANTIBODY HEAVY CHAIN 10090
780 4ONF 2 L 3D6 FAB ANTIBODY LIGHT CHAIN 10090
781 1OPG 1 L OPG2 FAB (LIGHT CHAIN) 9606
782 1OPG 2 H OPG2 FAB (HEAVY CHAIN) 9606
783 1JPS 1 L immunoglobulin Fab D3H44, light chain Fab fragment 9606
784 1JPS 2 H immunoglobulin Fab D3H44, heavy chain Fab fragment 9606
785 5NPJ 1 A, B Single chain variable fragment of the non-neutralizing antibody DAO5 10090
786 1NBY 1 A antibody kappa light chain first chain of Anti-Lysozyme Antibody HyHEL-63 light chain 10090
787 1NBY 2 B immunoglobulin gamma 1 chain second chain of Anti-Lysozyme Antibody HyHEL-63 10090
788 3V6O 2 C, D Monoclonal antibody 9F8 fab fragment Heavy chain Fab fragment of monoclonal antibody H chain 10090
789 3V6O 3 E, F Monoclonal antibody 9F8 fab fragment Light chain Fab fragment of monoclonal antibody L chain 10090
790 3S96 1 A, C 3B5H10 FAB heavy chain 10090
791 3S96 2 B, D 3B5H10 FAB light chain 10090
792 4LKX 1 A Fab fragment heavy chain 9606
793 4LKX 2 B Fab fragment light chain 9606
794 1Q9O 1 B, D S45-2 Fab (IgG1k) heavy chain Fab1 Heavy chain g1 10090
795 1Q9O 2 A, C S45-2 Fab (IgG1k) light chain Fab1 Light chain kappa 10090
796 3SE8 2 H Heavy chain of antibody VRC03 Antigen binding fragement of antibody heavy chain 9606
797 3SE8 3 L Light chain of antibody VRC03 antibody light chain 9606
798 5JW5 1 A, H MEDI8852 Heavy chain 9606
799 5JW5 2 B, L MEDI8852 Light chain 9606
800 5VH3 1 A, H Infliximab Fab Heavy Chain 10090
801 5VH3 2 B, L Infliximab Fab Light Chain 10090
802 6DCV 1 A, L Light chain of CBTAU27.1 Fab 9606
803 6DCV 2 B, H heavy chain of CBTAU-27.1 Fab 9606
804 5HDQ 2 H Fab Heavy Chain 10090
805 5HDQ 3 L Fab Light Chain 10090
806 4FQ2 1 H Fab heavy chain 9606
807 4FQ2 2 L Fab light chain 9606
808 3RKD 2 C, L Monoclonal Antibody, Light Chain 10090
809 3RKD 3 D, H Monoclonal Antibody, Heavy Chain 10090
810 3L1O 1 H MONOCLONAL ANTIBODY FAB FRAGMENT MN423 H CHAIN 10090
811 3L1O 2 L MONOCLONAL ANTIBODY FAB FRAGMENT MN423 L CHAIN 10090
812 2A77 1 L Immunoglobulin Light Chain 10090
813 2A77 2 H Immunoglobulin Heavy Chain 10090
814 2FB4 1 L IGG1-LAMBDA KOL FAB (LIGHT CHAIN) 9606
815 2FB4 2 H IGG1-LAMBDA KOL FAB (HEAVY CHAIN) 9606
816 3GO1 1 L Fab 268-D, light chain 9606
817 3GO1 2 H Fab 268-D, heavy chain 9606
818 1F3D 1 J, L CATALYTIC ANTIBODY 4B2 LIGHT CHAIN - FAB FRAGMENT 10090
819 1F3D 2 H, K CATALYTIC ANTIBODY 4B2 HEAVY CHAIN - FAB FRAGMENT 10090
820 3QWO 1 B, L motavizumab light chain 10090
821 3QWO 2 A, H motavizumab heavy chain 10090
822 3CVI 1 H 25-D1.16 Heavy chain 10090
823 3CVI 2 L 25-D1.16 Light chain 10090
824 1PZ5 1 A Light chain of Fab (SYA/J6) 10090
825 1PZ5 2 B Heavy chain of Fab (SYA/J6) 10090
826 1LK3 2 L, M 9D7 Light Chain Fab fragment, Residues 1-210 10116
827 1LK3 3 H, I 9D7 Heavy Chain Fab fragment, Residues 1-219 10116
828 4IOI 1 A Trastuzumab light chain 9606
829 4IOI 2 B Trastuzumab heavy chain 9606
830 1N7M 1 H Germline Metal Chelatase Catalytic Antibody, chain H 10090
831 1N7M 2 L Germline Metal Chelatase Catalytic Antibody, chain L 10090
832 4OKV 1 A, C heavy chain of 8H7 mAb 10090
833 4OKV 2 B, D light chain of 8H7 mAb 10090
834 6B5S 1 H CIS42 Fab Heavy chain 9606
835 6B5S 2 L CIS42 Fab Light chain 9606
836 5K8A 1 A, E, L, M humanized Fab Lite chain 10090
837 5K8A 2 B, F, H, V Heavy chain 10090
838 1JGV 1 L Antibody Light Chain 10090
839 1JGV 2 H Antibody Heavy Chain 10090
840 5VAG 2 B Light chain of antibody m826 9606
841 5VAG 3 C Heavy chain of antibody m826 9606
842 3MLX 1 L, M Human monoclonal anti-HIV-1 gp120 V3 antibody 3074 Fab light chain 9606
843 3MLX 2 H, I Human monoclonal anti-HIV-1 gp120 V3 antibody 3074 Fab heavy chain 9606
844 3I9G 1 H Sonepcizumab antibody Fab fragment, heavy chain Fab Fragment 10090
845 3I9G 2 L Sonepcizumab antibody Fab fragment, light chain Fab Fragment 10090
846 5GIR 1 A, H Heavy chain of Fab fragment 10090
847 5GIR 2 B, L Light chain of Fab fragment 10090
848 2ADF 2 H 82D6A3 IgG FAB 10090
849 2ADF 3 L 82D6A3 IgG FAB 10090
850 5I16 1 A, L FAB LIGHT CHAIN 9606
851 5I16 2 B, H FAB HEAVY CHAIN 9606
852 3O41 1 B, L Mouse monoclonal antibody 101F Fab light chain 10090
853 3O41 2 A, H Mouse monoclonal antibody 101F Fab heavy chain 10090
854 5F9O 2 H CH235.9 Heavy chain 9606
855 5F9O 3 L CH235.09 Light chain 9606
856 3Q6G 1 L, M Light chain of Fab of rhesus mAb 2.5B 9544
857 3Q6G 2 H, I Heavy chain of Fab of rhesus mAb 2.5B 9544
858 1UM4 1 L Antibody 21H3 L chain 10090
859 1UM4 2 H Antibody 21H3 H chain 10090
860 5VJQ 1 A, C, E, G HyHEL10 heavy chain Fab fragment carrying three mutations; I29F, S52T, Y53F DEL-I 10090 3.2.1.18 | Details
861 5VJQ 2 B, D, F, H HyHEL10 light chain Fab fragment 10090
862 4RBP 1 K, L Fab 2G12 light chain 9606
863 4RBP 2 H, M Fab 2G12 heavy chain 9606
864 3I75 1 A Antibody heavy chain 10090
865 3I75 2 B Antibody light chain 10090
866 4XVS 1 H VRC07_1995 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 Heavy chain 9606
867 4XVS 2 L 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 Light chain 9606
868 7FAB 1 L IGG1-LAMBDA NEW FAB (LIGHT CHAIN) 9606
869 7FAB 2 H IGG1-LAMBDA NEW FAB (HEAVY CHAIN) 9606
870 4FQL 1 H monoclonal antibody CR8033 heavy chain Fab 9606
871 4FQL 2 L monoclonal antibody CR8033 light chain Fab 9606
872 1NGX 1 A, L Germline Metal Chelatase Catalytic Antibody, Light chain germline Fab fragment 10090
873 1NGX 2 B, H Germline Metal Chelatase Catalytic Antibody, Heavy chain germline Fab fragment 10090
874 1E6O 1 H IMMUNOGLOBULIN HEAVY CHAIN OBTAINED BY PEPSIN CLEAVAGE (FAB') HEAVY CHAIN 1-219 10090
875 1E6O 2 L IMMUNOGLOBULIN LIGHT CHAIN OBTAINED BY PEPSIN CLEAVAGE (FAB') LIGHT CHAIN 1-210 10090
876 5GIS 1 H Heavy chain of Fab fragment 10090
877 5GIS 2 L Light chain of Fab fragment 10090
878 1JFQ 1 L ANTIGEN-BINDING FRAGMENT OF ANTI-PHENYLARSONATE ANTIBODY LIGHT CHAIN 10090
879 1JFQ 2 H ANTIGEN-BINDING FRAGMENT OF ANTI-PHENYLARSONATE ANTIBODY HEAVY CHAIN 10090
880 6B0S 1 H 1710 antibody, heavy chain 9606
881 6B0S 2 L 1710 antibody, light chain 9606
882 5FGC 2 B Anti-HCV E2 Fab HC33.8 light chain 9606
883 5FGC 3 E Anti-HCV E2 Fab HC33.8 heavy chain 9606
884 5GRX 1 G, H diabody protein 9606
885 6DCW 1 L Light chain of CBTAU27.1 Fab 9606
886 6DCW 2 H Heavy chain of CBTAU27.1 Fab 9606
887 6DB6 1 H Human monoclonal anti-HIV-1 gp120 V3 antibody 311-11D Fab heavy chain 9606
888 6DB6 2 L Human monoclonal anti-HIV-1 gp120 V3 antibody 311-11D Fab light chain 9606
889 4H20 1 L Light chain of Fab Fragment from the anti-Ricin Monoclonal Antibody RAC18 10090
890 4H20 2 H Heavy chain of Fab Fragment from the anti-Ricin Monoclonal Antibody RAC18 10090
891 5GGQ 1 L nivolumab light chain 9606
892 5GGQ 2 H nivolumab heavy chain 9606
893 4RFE 1 A, C, E, H Fab heavy chain of ADCC-potent anti-HIV-1 antibody JR4 9544
894 4RFE 2 B, D, F, L Fab light chain of ADCC-potent anti-HIV-1 antibody JR4 9544
895 6B5N 1 H CIS43 Fab Heavy chain 9606
896 6B5N 2 L CIS43 Fab Light chain 9606
897 3OAY 1 K, L Fab 2G12, light chain 9606
898 3OAY 2 H, M Fab 2G12, heavy chain 9606
899 1CR9 1 L FAB ANTIBODY LIGHT CHAIN HEAVY CHAIN 10090
900 1CR9 2 H FAB ANTIBODY HEAVY CHAIN LIGHT CHAIN 10090
901 6AND 2 H Pinatuzumab Fab Heavy chain 9606
902 6AND 3 L Pinatuzumab Fab light chain 9606
903 1A3L 1 L IMMUNOGLOBULIN FAB 13G5 (LIGHT CHAIN) IMMUNOGLOBULIN FAB FRAGMENT 10090
904 1A3L 2 H IMMUNOGLOBULIN FAB 13G5 (HEAVY CHAIN) IMMUNOGLOBULIN FAB FRAGMENT 10090
905 5W0D 2 B Lineage K03.12 UCA antibody heavy chain 9606
906 5W0D 3 C Lineage K03.12 UCA antibody light chain 9606
907 1YEJ 1 L PROTEIN (IG ANTIBODY D2.3 (LIGHT CHAIN)) ANTIGEN BINDING FRAGMENT 10090
908 1YEJ 2 H PROTEIN (IG ANTIBODY D2.3 (HEAVY CHAIN)) ANTIGEN BINDING FRAGMENT 10090
909 4GMT 1 L, M Fab S139/1 light chain 10090
910 4GMT 2 H, I Fab S139/1 heavy chain 10090
911 6BPB 1 A Monoclonal antibody 4F7 Fab heavy chain 10090
912 6BPB 2 B Monoclonal antibody 4F7 Fab light chain 10090
913 5K9J 1 H 56.a.09 heavy chain 9606
914 5K9J 2 L 56.a.09 light chain 9606
915 5DS8 1 A, H Fab Hpu98 Heavy Chain 9986
916 5DS8 2 B, L Fab Hou98 Light Chain 9986
917 3ZKM 2 C, H FAB HEAVY CHAIN 9606
918 3ZKM 3 D, L FAB LIGHT CHAIN 10090
919 1FNS 1 L IMMUNOGLOBULIN NMC-4 IGG1 FAB FRAGMENT, LIGHT CHAIN 10090
920 1FNS 2 H IMMUNOGLOBULIN NMC-4 IGG1 FAB FRAGMENT, HEAVY CHAIN 10090
921 5JRP 1 L marberg virus monoclonal antibody MR78 Fab light chain 9606
922 5JRP 2 H marberg virus monoclonal antibody MR78 Fab heavy chain 9606
923 3HNS 1 H CS-35 Fab Heavy Chain Heavy Chain 10090
924 3HNS 2 L CS-35 Fab Light Chain Light Chain 10090
925 1KEL 1 L 28B4 FAB THIS PROTEIN IS A FAB FRAGMENT PRODUCED UPON THE DIGESTION OF FULL-LENGTH MURINE MONOCLONAL ANTIBODY BY PAPAIN VARIABLE REGIONS OF LIGHT AND HEAVY CHAINS 10090
926 1KEL 2 H 28B4 FAB THIS PROTEIN IS A FAB FRAGMENT PRODUCED UPON THE DIGESTION OF FULL-LENGTH MURINE MONOCLONAL ANTIBODY BY PAPAIN VARIABLE REGIONS OF LIGHT AND HEAVY CHAINS 10090
927 4DCQ 1 A 3B5H10 FAB Light Chain 10090
928 4DCQ 2 B 3B5H10 FAB Heavy Chain 10090
929 5TF1 1 H 02-CC Fab Heavy chain 9606
930 5TF1 2 L O2-CC Fab Light Chain 9606
931 3TCL 1 A, H CH04 Heavy Chain Fab 9606
932 3TCL 2 B, L CH04 Light Chain Fab 9606
933 4OJF 1 H Humanised 3D6 Fab Heavy Chain 10090
934 4OJF 2 L Humanised 3D6 Fab Light Chain 10090
935 5F7E 1 H Fab heavy chain 3BNC60 germline heavy chain 9606
936 5F7E 2 L Fab light chain